- Why in news
- On 4 November 2026, the Health Ministry announced a proposed amendment to Schedule M of the Drugs Rules, 1945, notified as G.S.R. 953(E) on 28 October 2026. It would align Grade A microbial limits with WHO guidelines.
- What it is
- Schedule M of the Drugs Rules, 1945 sets Good Manufacturing Practices (GMP) and requirements for premises, plant and equipment for pharmaceutical products. The Drugs Rules are framed under the Drugs and Cosmetics Act, 1940. Schedule M has been revised to bring Indian manufacturers closer to international GMP norms.
- Proposing instrument
- The amendment is proposed through G.S.R. No. 953(E) dated 28 October 2026, issued by the Health Ministry.
- Grade A areas
- These are critical zones in sterile manufacturing where exposed products, containers and sterilised components are handled.
- Investigation trigger
- Any microbial growth detected in Grade A areas would be treated as a trigger for investigation, following WHO guidance.
- Consultation
- Stakeholders and the public can send objections and suggestions to the Under Secretary (Drugs Regulation) of the Health Ministry.
- Parent law
- The Drugs Rules, 1945 are made under the Drugs and Cosmetics Act, 1940.
- Gap addressed
- Existing curbs cover manufacturers only; sellers were not explicitly covered.
- Advisory body
- The proposal follows the 93rd meeting of the Drugs Technical Advisory Board, held on 16 February 2026.
- Consultation period
- Objections and suggestions are invited within 30 days of the Gazette copies being made available to the public.
- New power
- The Licensing Authority can debar further applications by entities that submit fake or fabricated data.
- Scope
- It applies to all applications filed under the various provisions of the Drugs Rules, 1945.
- Earlier position
- Earlier, the penalties were rejection of the application and/or cancellation of existing licences.
- Safeguards
- A show-cause notice must be issued before any such action, and an appeal is provided.
- Parent Act
- The Rules are made under the Drugs and Cosmetics Act, 1940.
Don’t confuse with Schedule M vs Schedules H, H1, X: Schedule M deals with manufacturing practices (GMP) and premises. Schedules H, H1 and X list prescription-only drugs and control their sale.
Don’t confuse with Schedule H vs H1 vs X: All are prescription-only lists. H1 (e.g. certain antibiotics) and X (e.g. narcotic and psychotropic substances) carry stricter record-keeping and storage rules.
Don’t confuse with Drugs Rules, 1945 vs Drugs and Cosmetics Act, 1940: The Act is the parent law passed by Parliament; the Rules are subordinate legislation made by the executive under it.
Don’t confuse with Drugs and Cosmetics Act, 1940 vs Drugs Rules, 1945: The Act is the parent law passed by Parliament. The Rules are subordinate legislation made under it by the Government, and amended by G.S.R. notifications.
Laws, judgments and statutory bodies: 30 Prelims questions since 2013 (what the law says, who chairs, legal basis). In Mains, 44 news-triggered questions, most in GS2, asking for provisions and challenges.
Why it matters
- Aligning with WHO norms improves the quality and safety of sterile medicines such as injectables.
- Harmonised standards help Indian exports and trust in Indian-made drugs.
- Closes a gap so the advertising curb covers the whole supply chain, not just manufacturers.
- Helps curb self-medication and misuse of antibiotics and psychotropic drugs.
- Strengthens the integrity of drug approvals by deterring fabricated data.
- Protects public health by ensuring approvals rest on reliable evidence.
Problems
- Small and medium manufacturers may find upgrading sterile facilities costly.
- Enforcement needs enough trained drug inspectors and regular audits.
- Enforcement across lakhs of retail outlets and online pharmacies is difficult.
- Drug control is shared between Centre and States, so uneven enforcement is likely.
- Debarment must be proportionate and follow due process, so authorities need capacity to verify data.
- Enforcement depends on State and Central regulators, whose capacity varies.
Way forward
- Give MSMEs time and support to upgrade, with clear technical guidance.
- Strengthen inspections and risk-based audits by central and state regulators.
- Finalise the rule after considering public comments, with clear definitions of what counts as an advertisement.
- Strengthen State drug-control capacity and monitor online sales and promotions.
- Strengthen data verification and audit capacity of regulators.
- Publish debarment decisions and keep the appeal process quick.
Put in your answer
Due process: The amendment requires a show-cause notice before debarment and provides an appeal, which balances deterrence and fairness.
- 2013Mains GS3 · Q14Define Fixed Dose Drug Combinations and discuss their merits and demerits.
- 2020Mains GS4 · Q4Distinguish between laws and rules, and discuss the role of ethics in framing them
- 2014Mains GS3 · Q11Whether free antibiotic sales cause drug resistance, and what monitoring and control mechanisms exist.
UPSC’s own questions that come close to this issue, from our Prelims and Mains banks.
Prelims practice · Single answer
Ours, not from a UPSC paper
Consider the following statements regarding the draft amendment to the Drugs Rules, 1945 announced by the Union Health Ministry:
Which one of the following is correct?
True or false?
1 of 6
Statements the way Prelims prints them. Say first, then see the fact.
1.The draft amendment proposes to insert a new sub-rule (22) under Rule 65 of the Drugs Rules, 1945.
True. Sub-rule (22) is proposed under Rule 65.
2.Before this draft, the prior-sanction requirement for advertising Schedule H, H1 and X drugs applied to manufacturers.
True. Existing curbs bound manufacturers; sellers were not explicitly covered.
3.The proposed sanction for advertising these drugs would have to be given by the respective State Governments.
False. The previous sanction must come from the Central Government.
4.The proposal follows recommendations of the Drugs Technical Advisory Board.
True. The 93rd DTAB meeting on 16 February 2026 considered it.
5.The Drugs Rules, 1945 are framed under the Drugs and Cosmetics Act, 1940.
True. The Rules are delegated legislation under the 1940 Act.
6.The Drugs Technical Advisory Board is a body set up under the Consumer Protection Act, 2019.
False. DTAB is constituted under the Drugs and Cosmetics Act, 1940.
Written by us from the release, not by UPSC; checked by a second model.
Worth revising until Prelims 2028: most news questions come within two years of the event.